BACKGROUND. Acute and chronic rhinosinusitis (CRS) are common conditions worldwide. In most cases, the etiology of acute rhinosinusitis (ARS) is viral, but there can be cases complicated by bacterial infection. The bacterial pathogens responsible for acute bacterial rhinosinusitis (ABRS) in most cases are Streptococcus pneumoniae, Haemophilus influenza and Moraxella catarrhalis. In recent years, some changes regarding this issue have been communicated. Also, the pathophysiology of CRS becomes a problem due to the increasing percentage of resistant or recurrent cases.
OBJECTIVE. To identify the bacterial spectrum in patients diagnosed with ABRS and CRS and to establish the actual resistance rates of the most prescribed antibiotics for these affections in order to initiate the correct antibiotic treatment.
MATERIAL AND METHODS. We performed a prospective study on 40 adult patients with ABRS and 70 patients with CRS. The standard microbiological procedures were performed in order to identify the involved microorganisms. The Antibiotic Susceptibility Test of the clinical isolates was performed to routinely used antibiotics according to EUCAST.
RESULT. ABRS: A total of 21 types of pathogenic bacteria were isolated. The results indicated changes in the percentages of the traditionally involved bacteria, other species of streptococci and Staphylococcus aureus representing important pathogens. Almost half of the samples were polymicrobial. CRS: 12 bacteria were incriminated for CRS, Staphylococcus aureus and Pseudomonas aeruginosa being the most frequently identified pathogens. Regarding the antibiotic treatment, we established that in our country the resistance rates are higher than the ones communicated by WHO (especially for macrolides) and the fluoroquinolones seem to be the class with the highest safety profile.
CONCLUSION. Study results demonstrate some changes of the bacteriologic spectrum in ABRS in this geographic area. The pathogens responsible for CRS are found in approximately the same percentage as presented in other studies. Antibiotic treatment demands attention considering the increasing trend of antibiotic resistance of the bacteria causing ABRS and CRS.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. Fokkens WJ Lund VJ Mullol J Bachert C Alobid I Baroody F et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. Rhinology. 2012;50(Suppl 23):1-298.
2. Jousimies-Somer HR Savolainen S Ylikoski JS. Bacteriological findings of acute maxillary sinusitis in young adults. J Clin Microbiol. 1988;26(10):1919–25.
3. Brook I. Discrepancies in the recovery of bacteria from multiple sinuses in acute and chronic sinusitis. Journal of Medical Microbiology. 2004;53:879–85. DOI: 10.1099/jmm.0.45655-0.
4. Sabaru I Neagu A. Acute bacterial rhinosinusitis: new aspects regarding bacterial spectrum and microbiologic diagnosis. Romanian Journal of Rhinology. 2014;4(14):111-6.
5. Wang DY Wardani RS Singh K Thanaviratananich S Vicente G Xu G et al. A survey on the management of acute rhinosinusitis among Asian physicians. Rhinology. 2011;49(3):264-71. DOI: 10.4193/Rhino10.169.
6. Revai K Dobbs LA Nair S Patel JA Grady JJ Chonmaitree T. Incidence of acute otitis media and sinusitis complicating upper respiratory tract infection: the effect of age. Pediatrics. 2007;119(6):e1408-12.
7. Udayasri B Radhakumari T. Microbial etiology of chronic sinusitis. IOSR-JDMS. 2016;15(1):118-24.
8. Brook I Gober AE. Frequency of recovery of pathogens from the nasopharynx of children with acute maxillary sinusitis before and after the introduction of vaccination with the 7-valent pneumococcal vaccine. Int J Pediatr Otorhinolaryngol. 2007;71(4):575-9. Epub 2007 Jun 30.
9. Mustafa M Patawari P Iftikhar HM Shimmi SC Hussain SS Sien MM. Acute and chronic rhinosinusitis pathophysiology and treatment. International Journal of Pharmaceutical Science Invention. 2015;4(2):30-6.
10. Thanaviratananich S Chusakul S Moungthong G Luxameechanporn T Tantilipikorn P Fooanant S et al. A Surveillance Bacteriological Study of Acute Bacterial Rhinosinusitis in Thailand and the Clinical Responses to the Culture-directed Antibiotics. J Med Assoc Thai. 2015;98 Suppl 7:S204-16.
11. Pourmousa R Dadashzadeh R Ahangarkani F Rezai MS. Frequency of Bacterial Agents Isolated From Patients With Chronic Sinusitis in Northern Iran. Glob J Health Sci. 2015;8(5):239-46. DOI: 10.5539/gjhs.v8n5p239.
12. Suh JD Cohen NA Palmer JN. Biofilms in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2010;18(1):27-31. DOI: 10.1097/MOO.0b013e328334f670.
13. Suh JD Ramakrishnan V Palmer JN. Biofilms. Otolaryngol Clin North Am. 2010;43(3):521-30 viii. DOI: 10.1016/j.otc.2010.02.010.
14. Sanderson AR Leid JG Hunsaker D. Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis. Laryngoscope. 2006;116(7):1121-6.
15. Prince AA Steiger JD Khalid AN Dogrhamji L Reger C Eau Claire S et al. Prevalence of biofilm-forming bacteria in chronic rhinosinusitis. Am J Rhinol. 2008;22(3):239-45. DOI: 10.2500/ajr.2008.22.3180.
16. Foreman A Psaltis AJ Tan LW Wormald PJ. Characterization of bacterial and fungal biofilms in chronic rhinosinusitis. Am J Rhinol Allergy. 2009;23(6):556-61. DOI: 10.2500/ajra.2009.23.3413.